Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2019

09.03.2019

Pacemaker implantation in familial amyloid polyneuropathy: when and for whom?

verfasst von: James Milner, Rafaela Nicolau Teixeira, Ana Vera Marinho, Nuno Silva, Suzana Calretas, José Ferrão, Emanuel Furtado, Maria João Telo, Miguel Ventura, João Cristóvão, Luís Elvas, Guilherme Mariano Pêgo, Natália António

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Despite the important role of cardiac pacing in preventing syncope and sudden cardiac death in familial amyloid polyneuropathy (FAP), we lack clear guidelines as to the ideal timing and indications for permanent pacemaker implantation. Purpose: The purpose of this study was to evaluate the ideal timing for pacemaker implantation in FAP patients submitted to liver transplantation.

Methods

Retrospective study of 258 FAP patients submitted to liver transplantation between 1992 and 2012. Comparison of three groups: (A) patients without pacemaker (N = 122); (B) patients submitted to pacemaker implantation after liver transplantation, with documented conduction disorders (N = 73); and (C) patients submitted to “prophylactic” pacemaker implantation before transplantation, (N = 73). Patients were followed up for 12.2 ± 6.7 years.

Results

The majority of patients (57%) were referred for pacemaker implantation, which occurred before liver transplantation in 50% of cases. Patients who required pacemaker after transplantation presented significantly higher Machado-Joseph Score during pre-transplant evaluation than those who did not require pacemaker (24 ± 10 vs 20 ± 10, p = .025), and also exhibited higher levels of hepatic cytolysis enzymes and hyperbilirubinemia. The most common indication for permanent pacemaker was first degree atrioventricular block, with a mean time between transplantation and pacemaker implantation of 8.7 ± 4.2 years. During long-term follow-up, all-cause mortality was 27% and was lowest in the group submitted to pacemaker implantation only after liver transplantation (p = 0.002).

Conclusion

The majority of FAP patients submitted to liver transplantation will need a pacemaker at some time of follow-up. However, it seems that there is no benefit in “prophylactic” cardiac pacing before liver transplantation.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gertz M, Benson M, Dyck P. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2451–66.CrossRefPubMed Gertz M, Benson M, Dyck P. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2451–66.CrossRefPubMed
3.
Zurück zum Zitat Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75:408–27.CrossRefPubMed Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75:408–27.CrossRefPubMed
4.
Zurück zum Zitat Fonseca C, Ceia F, Carvalho A. História Natural do envolvimento cardíaco na polineuropatia familiar do tipo português. Rev Port Cardiol. 1997;16:101–5.PubMed Fonseca C, Ceia F, Carvalho A. História Natural do envolvimento cardíaco na polineuropatia familiar do tipo português. Rev Port Cardiol. 1997;16:101–5.PubMed
5.
Zurück zum Zitat Hörnsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid. 2010;17:63–8.CrossRefPubMed Hörnsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB. Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid. 2010;17:63–8.CrossRefPubMed
6.
Zurück zum Zitat Viana J, Romero A, Vieira H, Neves S, Bento C, Seco C, et al. Cardiac pacing in patients subjected to liver transplant for familial amyloidosis Met30 - evaluation of a 10-year experience with 143 patients. Eur J Anaesthesiol. 2003;90:49. Viana J, Romero A, Vieira H, Neves S, Bento C, Seco C, et al. Cardiac pacing in patients subjected to liver transplant for familial amyloidosis Met30 - evaluation of a 10-year experience with 143 patients. Eur J Anaesthesiol. 2003;90:49.
7.
Zurück zum Zitat Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Neurol Rev. 2015;62:1057–62. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Neurol Rev. 2015;62:1057–62.
8.
Zurück zum Zitat Sousa A, Coelho T, Barros J, Segueiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet. 1995;60:512–21.CrossRefPubMed Sousa A, Coelho T, Barros J, Segueiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet. 1995;60:512–21.CrossRefPubMed
9.
Zurück zum Zitat Azevedo Coutinho M, Cortez-Diaz N, Cantinho G, Conceição I, Guimarães T, Lima da Silva G, et al. Progression of myocardial sympathetic denervation assessed by 123I-MIBG imaging in familial amyloid polyneuropathy and the effect of liver transplantation. Rev Port Cardiol. 2017;36:333–40.CrossRefPubMed Azevedo Coutinho M, Cortez-Diaz N, Cantinho G, Conceição I, Guimarães T, Lima da Silva G, et al. Progression of myocardial sympathetic denervation assessed by 123I-MIBG imaging in familial amyloid polyneuropathy and the effect of liver transplantation. Rev Port Cardiol. 2017;36:333–40.CrossRefPubMed
10.
Zurück zum Zitat Adams D. Recent advances in the treatment of familial amyloid polyneuropathy. Ther Adv Neurol. 2013;6:129–39.CrossRef Adams D. Recent advances in the treatment of familial amyloid polyneuropathy. Ther Adv Neurol. 2013;6:129–39.CrossRef
11.
Zurück zum Zitat Monteiro E, Perdigoto R, Furtado A. Liver transplantation for familial amyloid polyneuropathy. Hepato-Gastroenterology. 1998;45:1375–80.PubMed Monteiro E, Perdigoto R, Furtado A. Liver transplantation for familial amyloid polyneuropathy. Hepato-Gastroenterology. 1998;45:1375–80.PubMed
12.
Zurück zum Zitat Suht O, Holmgren G, Steen L, Wikström L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation. 1995;60:933–8.CrossRef Suht O, Holmgren G, Steen L, Wikström L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation. 1995;60:933–8.CrossRef
13.
Zurück zum Zitat Algalarrondo V, Dinanian S, Juin C, CHemla D, Bennani SL, Sebag C, et al. Prophylactic pacemaker implantation in familial amyloid polyneuropathy. Heart Rhythm. 2012;9:1069–75.CrossRefPubMed Algalarrondo V, Dinanian S, Juin C, CHemla D, Bennani SL, Sebag C, et al. Prophylactic pacemaker implantation in familial amyloid polyneuropathy. Heart Rhythm. 2012;9:1069–75.CrossRefPubMed
14.
Zurück zum Zitat Hörnsten R, Wiklund U, Olofsson B, Jensen S, Suhr O. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation. 2004;78:112–6.CrossRefPubMed Hörnsten R, Wiklund U, Olofsson B, Jensen S, Suhr O. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation. 2004;78:112–6.CrossRefPubMed
15.
Zurück zum Zitat Yamamoto S, Wilczek H, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant. 2007;7:2597–604.CrossRefPubMed Yamamoto S, Wilczek H, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant. 2007;7:2597–604.CrossRefPubMed
Metadaten
Titel
Pacemaker implantation in familial amyloid polyneuropathy: when and for whom?
verfasst von
James Milner
Rafaela Nicolau Teixeira
Ana Vera Marinho
Nuno Silva
Suzana Calretas
José Ferrão
Emanuel Furtado
Maria João Telo
Miguel Ventura
João Cristóvão
Luís Elvas
Guilherme Mariano Pêgo
Natália António
Publikationsdatum
09.03.2019
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2019
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-019-00517-y

Weitere Artikel der Ausgabe 2/2019

Journal of Interventional Cardiac Electrophysiology 2/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.